MENU
+Compare
HLBBF
Stock ticker: OTC
AS OF
Aug 29 closing price
Price
$6.38
Change
+$0.87 (+15.76%)
Capitalization
6.17B

HLBBF H. Lundbeck A/S Forecast, Technical & Fundamental Analysis

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLBBF with price predictions
Sep 05, 2025

HLBBF in downward trend: price may decline as a result of having broken its higher Bollinger Band on August 29, 2025

HLBBF broke above its upper Bollinger Band on August 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 11 similar instances where the stock broke above the upper band. In of the 11 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for HLBBF entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 24 cases where HLBBF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on HLBBF as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HLBBF just turned positive on August 12, 2025. Looking at past instances where HLBBF's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .

HLBBF moved above its 50-day moving average on August 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HLBBF crossed bullishly above the 50-day moving average on August 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for HLBBF moved above the 200-day moving average on September 03, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLBBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.676) is normal, around the industry mean (16.653). P/E Ratio (11.612) is within average values for comparable stocks, (74.307). HLBBF's Projected Growth (PEG Ratio) (7.604) is very high in comparison to the industry average of (1.902). Dividend Yield (0.022) settles around the average of (0.031) among similar stocks. P/S Ratio (1.723) is also within normal values, averaging (42.886).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLBBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JCHI54.730.94
+1.74%
JPMorgan Active China ETF
SHOC56.810.81
+1.44%
Strive U.S. Semiconductor ETF
FLCB21.670.10
+0.46%
Franklin U.S. Core Bond ETF
BRIF28.590.08
+0.27%
FIS Bright Portfolios Focused Equity ETF
NUMG48.81-0.18
-0.38%
Nuveen ESG Mid-Cap Growth ETF

HLBBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLBBF has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLBBF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
DRRX - HLBBF
38%
Loosely correlated
N/A
BNXTF - HLBBF
27%
Poorly correlated
+2.55%
HLUBF - HLBBF
19%
Poorly correlated
N/A
HLNCF - HLBBF
8%
Poorly correlated
-0.61%
HLN - HLBBF
4%
Poorly correlated
-0.41%
More

Groups containing HLBBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
Pharmaceuticals: Generic
industry (222 stocks)
8%
Poorly correlated
-0.21%